Showing results (311-320 of 556) with videos related to

Sort By:
Pageof 56
Cytometry. Part B, Clinical Cytometry|August 20, 2020
Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusionPrashant R Tembhare, Gaurav Chatterjee, Twinkle Khanka, et al.
Indian Journal of Pathology & Microbiology|June 21, 2017
An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemiaNikhil Patkar, P G Subramanian, Prashant Tembhare, et al.
South Asian Journal of Cancer|September 7, 2019
Palliative chemotherapy in carcinoma nasopharynxVijay M Patil, Amit Joshi, Vanita Noronha, et al.
Lung Cancer Management|January 16, 2019
Curative intent therapy in oligometastatic lung cancer with an unresectable primary with N3 nodes: case report and review of the literatureVanita Noronha, Amit Joshi, Vijay M Patil, et al.
Indian Journal of Surgical Oncology|December 7, 2020
Robotic Total Mesorectal Excision for Rectal Cancer: Short-Term Oncological Outcomes of Initial 178 CasesC Ramachandra, Pavan Sugoor, Uday Karjol, et al.
Head & Neck|March 9, 2021
Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single instituteSarbani Ghosh Laskar, Prathamesh Pai, Shwetabh Sinha, et al.
American Journal of Hematology|November 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) CohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
Annals of Hematology|July 21, 2023
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, IndiaNirmalya Roy Moulik, Swaminathan Keerthivasagam, Swetha V Velagala, et al.
Cytometry. Part B, Clinical Cytometry|September 8, 2020
Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemiaGaurav Chatterjee, Harshini Sriram, Sitaram Ghogale, et al.
Translational Oncology|June 2, 2022
Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutationAsim Joshi, Ashwin Butle, Supriya Hait, et al.
Pageof 56